PATENT CLAIM ANALYSIS

Application Number: 15923650
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "373000"]

Abstract:
Disclosed herein are methods of treating conditions, which may be associated with elevated levels of eosinophils and/or basophils, with a therapeutically effective amount of dexpramipexole or pharmaceutical acceptable salt thereof.

Claim (Index 2):
The method of  claim 1 , wherein the gastrointestinal disease is selected from the group consisting of sclerosing cholangitis, irritable bowel disease, ulcerative colitis, sclerosing cholangitis, eosinophilic esophagitis, eosinophilic gastroenteritis, inflammatory bowel diseases, eosinophilic colitis, gluten sensitivity, Cronkhite-Canada syndrome, and any combination thereof.

Metadata:
- Claim Count in Document: 95.0
- Percentile: 90.0
- Lexical Diversity: 1.13793
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15889714', '14912015', '15675912', '15461131', '15181526']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8442192280879252
- 35 USC 102 Novelty (BERT): 0.578072832544786
- Combined Prediction Score: 0.8176045885336113
- Mean Citation Score: 526.019278
- Max Citation Score: 617.0143400000002
- Similarity Product: 350.2999476441122

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test